Oxprenolol in thyrotoxicosis.
D000818:Animals; D002395:Catecholamines / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D010096:Oxprenolol / Q000627:therapeutic use*; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use
D002395:Catecholamines; D010919:Placebos; D010096:Oxprenolol; D011433:Propranolol